Senator Klobuchar praises new lower prices for weight loss drugs, attributing savings to Medicare price negotiations legislation.
Quiver AI Summary
Klobuchar responds to new drug pricing: U.S. Senator Amy Klobuchar (D-MN) issued a statement welcoming the negotiated lower prices for weight loss drugs, including Ozempic, for Medicare beneficiaries. She attributes this change to her leadership in passing a Medicare drug price negotiations law in 2022, stating, "For too long, big drug companies have put profits ahead of the health and well-being of the American people."
Senator Klobuchar's legislative efforts: Klobuchar has spearheaded multiple initiatives aimed at reducing drug prices, such as the Empowering Medicare Seniors to Negotiate Drug Prices Act and the recently reintroduced Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act. These efforts include promoting competition and limiting practices that delay the introduction of affordable medications.
Future goals for drug pricing reform: Klobuchar's ongoing efforts include bipartisan legislation aimed at saving taxpayers $1.9 billion over the next decade. The Preserving Access to Affordable Generics and Biosimilars Act aims to curb anti-competitive practices, while the STALLING Act seeks to prevent delays in the approval of generic drugs, improving access to affordable medication for consumers.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Amy Klobuchar Net Worth
Quiver Quantitative estimates that Amy Klobuchar is worth $2.3M, as of November 7th, 2025. This is the 241st highest net worth in Congress, per our live estimates.
Klobuchar has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Amy Klobuchar's net worth on Quiver Quantitative's politician page for Klobuchar.
Amy Klobuchar Bill Proposals
Here are some bills which have recently been proposed by Amy Klobuchar:
- S.3040: Edith Nourse Rogers STEM Scholarship Opportunity Act of 2025
- S.2822: Register America to Vote Act of 2025
- S.2820: Same Day Registration Act
- S.2725: STOP Act 2.0
- S.2724: Safe at Home Act
- S.2723: Treatment Court, Rehabilitation, and Recovery Act of 2025
You can track bills proposed by Amy Klobuchar on Quiver Quantitative's politician page for Klobuchar.
Amy Klobuchar Fundraising
Amy Klobuchar recently disclosed $469.2K of fundraising in a Q3 FEC disclosure filed on October 15th, 2025. This was the 181st most from all Q3 reports we have seen this year. 96.0% came from individual donors.
Klobuchar disclosed $607.8K of spending. This was the 72nd most from all Q3 reports we have seen from politicians so far this year.
Klobuchar disclosed $1.8M of cash on hand at the end of the filing period. This was the 200th most from all Q3 reports we have seen this year.
You can see the disclosure here, or track Amy Klobuchar's fundraising on Quiver Quantitative.
